176 related articles for article (PubMed ID: 21913903)
1. Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency.
Fanin M; Anichini A; Cassandrini D; Fiorillo C; Scapolan S; Minetti C; Cassanello M; Donati MA; Siciliano G; D'Amico A; Lilliu F; Bruno C; Angelini C
Clin Genet; 2012 Sep; 82(3):232-9. PubMed ID: 21913903
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency.
Anichini A; Fanin M; Vianey-Saban C; Cassandrini D; Fiorillo C; Bruno C; Angelini C
Neurol Res; 2011 Jan; 33(1):24-32. PubMed ID: 20810031
[TBL] [Abstract][Full Text] [Related]
3. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients.
Joshi PR; Deschauer M; Zierz S
J Neurol Sci; 2014 Mar; 338(1-2):107-11. PubMed ID: 24398345
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations associated with carnitine palmitoyltransferase II deficiency.
Taggart RT; Smail D; Apolito C; Vladutiu GD
Hum Mutat; 1999; 13(3):210-20. PubMed ID: 10090476
[TBL] [Abstract][Full Text] [Related]
5. Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: functional analysis and association with polymorphic haplotypes and two clinical phenotypes.
Wataya K; Akanuma J; Cavadini P; Aoki Y; Kure S; Invernizzi F; Yoshida I; Kira J; Taroni F; Matsubara Y; Narisawa K
Hum Mutat; 1998; 11(5):377-86. PubMed ID: 9600456
[TBL] [Abstract][Full Text] [Related]
6. Mutations of carnitine palmitoyltransferase II (CPT II) in Japanese patients with CPT II deficiency.
Yasuno T; Kaneoka H; Tokuyasu T; Aoki J; Yoshida S; Takayanagi M; Ohtake A; Kanazawa M; Ogawa A; Tojo K; Saito T
Clin Genet; 2008 May; 73(5):496-501. PubMed ID: 18363739
[TBL] [Abstract][Full Text] [Related]
7. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
Joshi PR; Zierz S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.
Martín MA; Rubio JC; del Hoyo P; García A; Bustos F; Campos Y; Cabello A; Culebras JM; Arenas J
Hum Mutat; 2000 Jun; 15(6):579-80. PubMed ID: 10862092
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency.
Taroni F; Verderio E; Fiorucci S; Cavadini P; Finocchiaro G; Uziel G; Lamantea E; Gellera C; DiDonato S
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8429-33. PubMed ID: 1528846
[TBL] [Abstract][Full Text] [Related]
10. Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency.
Yang BZ; Ding JH; Dewese T; Roe D; He G; Wilkinson J; Day DW; Demaugre F; Rabier D; Brivet M; Roe C
Mol Genet Metab; 1998 Aug; 64(4):229-36. PubMed ID: 9758712
[TBL] [Abstract][Full Text] [Related]
11. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
Lehmann D; Motlagh L; Robaa D; Zierz S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
[TBL] [Abstract][Full Text] [Related]
12. A splice junction mutation in muscle carnitine palmitoyltransferase II deficiency.
Deschauer M; Chrzanowska-Lightowlers ZM; Biekmann E; Pourfarzam M; Taylor RW; Turnbull DM; Zierz S
Mol Genet Metab; 2003 Jun; 79(2):124-8. PubMed ID: 12809643
[TBL] [Abstract][Full Text] [Related]
13. First Japanese Case of Carnitine Palmitoyltransferase II Deficiency with the Homozygous Point Mutation S113L.
Shima A; Yasuno T; Yamada K; Yamaguchi M; Kohno R; Yamaguchi S; Kido H; Fukuda H
Intern Med; 2016; 55(18):2659-61. PubMed ID: 27629963
[TBL] [Abstract][Full Text] [Related]
14. Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.
Yao M; Cai M; Yao D; Xu X; Yang R; Li Y; Zhang Y; Kido H; Yao D
PLoS One; 2015; 10(3):e0119936. PubMed ID: 25781464
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency.
Vladutiu GD; Bennett MJ; Fisher NM; Smail D; Boriack R; Leddy J; Pendergast DR
Muscle Nerve; 2002 Oct; 26(4):492-8. PubMed ID: 12362414
[TBL] [Abstract][Full Text] [Related]
16. Severe infantile type of carnitine palmitoyltransferase II (CPT II) deficiency due to homozygous R503C mutation.
Spiegel R; Shaag A; Gutman A; Korman SH; Saada A; Elpeleg O; Shalev SA
J Inherit Metab Dis; 2007 Apr; 30(2):266. PubMed ID: 17372854
[TBL] [Abstract][Full Text] [Related]
17. Carnitine palmitoyltransferase II deficiency: diagnosis by molecular analysis of blood.
Kaufmann P; el-Schahawi M; DiMauro S
Mol Cell Biochem; 1997 Sep; 174(1-2):237-9. PubMed ID: 9309694
[TBL] [Abstract][Full Text] [Related]
18. Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient.
Thuillier L; Sevin C; Demaugre F; Brivet M; Rabier D; Droin V; Aupetit J; Abadi N; Kamoun P; Saudubray JM; Bonnefont JP
Neuromuscul Disord; 2000 Mar; 10(3):200-5. PubMed ID: 10734268
[TBL] [Abstract][Full Text] [Related]
19. Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
Joshi PR; Deschauer M; Zierz S
Wien Klin Wochenschr; 2012 Dec; 124(23-24):851-4. PubMed ID: 23184072
[TBL] [Abstract][Full Text] [Related]
20. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
Isackson PJ; Bennett MJ; Lichter-Konecki U; Willis M; Nyhan WL; Sutton VR; Tein I; Vladutiu GD
Mol Genet Metab; 2008 Aug; 94(4):422-427. PubMed ID: 18550408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
